Published Reports from the Long Island Breast Cancer Study Project (LIBCSP)

• The Long Island Breast Cancer Study Project, Nature Reviews Cancer, Dec. 2005
• Report to the U.S. Congress, Long Island Breast Cancer Study Project, Nov. 2004 [PDF - 472 KB]
• Interim Report on the LIBCSP, June 2000
• Published Reports by Investigators, 1995 to 2009

  Breast Cancer and the Environment on Long Island

  Marilie D. Gammon, PhD
  University of North Carolina at Chapel Hill, N.C.
  (Formerly at Columbia University, NY)

  Gammon MD, Wolff MS, Neugut AI, Terry MB, Britton JA, Greenebaum E, Hibshoosh H, Levin B, Wang Q, Santella RM. Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiol Biomarkers Prev 1996 Jun;5(6):467-71.

  Gammon MD, Wolff MS, Neugut AI, Terry MB, Papadopoulos K, Levin B, Wang Q, Santella RM. Temporal variation in chlorinated hydrocarbons in healthy women. Cancer Epidemiol Biomarkers Prev 1997 May;6(5):327-32.

  Beyea J. Geographic exposure modeling: a valuable extension of geographic information systems for use in environmental epidemiology. Environ Health Perspect 1999 Feb;107 Suppl 1:181-90.

  Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Wolff MS, Stellman SD, Kabat GC, Levin B, Bradlow HL, Hatch M, Beyea J, Camann D, Trent M, Senie RT, Garbowski GC, Maffeo C, Montalvan P, Berkowitz GS, Kemeny M, Citron M, Schnabe F, Schuss A, Hajdu S, Vincguerra V, Collman GW, Obrams GI. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 2002 Jun;74(3):235-54.

  • UNC Fact Sheet:

  Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 2002 Aug;11(8):677-85.

  Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL, Britton JA, Terry MB, Levin B, Stellman SD, Kabat GC, Hatch M, Senie R, Berkowitz G, Bradlow HL, Garbowski G, Maffeo C, Montalvan P, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V, Niguidula N, Ireland K, Santella RM. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 2002 Aug;11(8):686-97.

  Teitelbaum SL. Questionnaire assessment of nonoccupational pesticide exposure in epidemiologic studies of cancer. J Expo Anal Environ Epidemiol 2002 Sep;12(5):373-80.

  Faraglia B, Chen SY, Gammon MD, Zhang Y, Teitelbaum SL, Neugut AI, Ahsan H, Garbowski GC, Hibshoosh H, Lin D, Kadlubar FF, Santella RM. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis 2003 Apr;24(4):719-25.

  Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 2004 May 26;291(20):2433-40. Accompanying editorial: DuBois RN. JAMA 2004 May 26;291(20):2488-9 (not available online).

  Gaudet MM, Britton JA, Kabat GC, Steck-Scott S, Eng SM, Teitelbaum SL, Terry MB, Neugut AI, Gammon MD. Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev 2004 Sep;13(9):1485-94.

  Gammon MD, Eng SM, Teitelbaum SL, Britton JA, Kabat GC, Hatch M, Paykin AB, Neugut AI, Santella RM. Environmental tobacco smoke and breast cancer incidence. Environ Res 2004 Oct;96(2):176-85.

  Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Josephy PD, Ambrosone C. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 2004 Oct 15;64(20):7634-9.

  Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, Wang Q, Hayes S, Teitelbaum SL, Neugut AI, Santella RM. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2053-8.

  Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005 Feb 15;65(4):1606-14.

  Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev 2005 Feb;14(2):336-42.

  Shantakumar S, Gammon MD, Eng SM, Sagiv SK, Gaudet MM, Teitelbaum SL, Britton JA, Terry MB, Paykin A, Young TL, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Camann D, Prokopczyk B, Kabat GC, Levin B, Neugut AI, Santella RM. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. J Expo Anal Environ Epidemiol 2005 Nov;15(6):482-90. Epub 2005 Apr 27.

  Shen J, Terry MB, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005 Dec;26(12):2131-7. Epub 2005 Jul 13.

  Eng SM, Gammon MD, Terry MB, Kushi LH, Teitelbaum SL, Britton JA, Neugut AI. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol 2005 Aug 1;162(3):229-37.

  Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 2005 Sep;14(9):2224-36.

  Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, Ambrosone CB. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005 Sep 28; [Epub ahead of print]

  Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol 2005 Oct 13; [Epub ahead of print]

  Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Ambrosone CB. No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005 Oct;14(10):2459-61. (No abstract available.)

  Gaudet MM, Gammon MD, Santella RM, Britton JA, Teitelbaum SL, Eng SM, Terry MB, Bensen JT, Schroeder J, Olshan AF, Neugut AI, Ambrosone CB. MnSOD Val-9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes Control 2005 Dec;16(10):1225-34.

  Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM, Conway K. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 2005 Dec 6; [Epub ahead of print]

  Santella RM, Gammon M, Terry M, Senie R, Shen J, Kennedy D, Agrawal M, Faraglia B, Zhang FF. DNA adducts, DNA repair genotype/phenotype and cancer risk. Mutat Res 2005 Dec 30;592 (1-2): 29-35.

  Kabat GC, O'Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Bradlow HL. Estrogen metabolism and breast cancer. Epidemiology 2006 Jan;17(1):80-8.

  Terry MB, Gammon MD, Zhang FF, Knight JA, Wang Q, Britton JA, Teitelbaum SL, Neugut AI, Santella RM. ADH3 genotype, alcohol intake, and breast cancer risk. Carcinogenesis 2006 Apr;27(4):840-7. Epub 2005 Dec 12.

  Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM, Conway K. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 2006 Apr;27(4):758-765; [Epub 2005 Dec 6]

  Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 2006 Sep;27(9):1876-82. Epub 2006 Apr 19.

  Rossner P Jr, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006 Apr;15(4):811-5.

  Rossner P Jr, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006 Apr;15(4):639-44.

  Beyea J, Hatch M, Stellman SD, Santella RM, Teitelbaum SL, Prokopczyk B, Camann D, Gammon MD. Validation and calibration of a model used to reconstruct historical exposure to polycyclic aromatic hydrocarbons for use in epidemiologic studies. Environ Health Perspect. 2006 Jul;114(7):1053-8.

  Shen J, Beth Terry M, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk. Breast Cancer Res Treat. 2006 Sep;99(1):1-7. Epub 2006 Jun 5.

  Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Res Treat. 2006 Sep;99(2):235-40. Epub 2006 Apr 5.

  Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD. Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat 2006 Oct 11; [Epub ahead of print]

  Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in the cyclooxygenase-2 gene, use of NSAIDs and breast cancer risk. Breast Cancer Res 2006 Dec 20;8(6):R71 [Epub ahead of print]

  Fink BN, Steck SE, Wolff MS, Kabat GC, Gammon MD. Construction of a flavonoid database for assessing intake in a population-based sample of women on Long Island, New York. Nutr Cancer 2006;56(1):57-66.

  Teitelbaum SL, Gammon MD, Britton JA, Neugut AI, Levin B, Stellman SD. Reported Residential Pesticide Use and Breast Cancer Risk on Long Island, New York. Am J Epidemiol 2006 Dec 13; [Epub ahead of print]

  Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary Flavonoid Intake and Breast Cancer Risk among Women on Long Island. Am J Epidemiol 2006 Dec 11; [Epub ahead of print]

  Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis. 2007 Jul;28(7):1504-9. Epub 2007 Mar 19.

  Xu X, Gammon MD, Wetmur JG, Rao M, Gaudet MM, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr. 2007 Apr;85(4):1098-102.

  Terry MB, Perrin M, Salafia CM, Zhang FF, Neugut AI, Teitelbaum SL, Britton J, Gammon MD. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol. 2007 May 1;165(9):1007-14. Epub 2007 Feb 6.

  Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol. 2007 May 15;165(10):1187-98. Epub 2007 Mar 3.

  Steck SE, Gaudet MM, Eng SM, Britton JA, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Cooked meat and risk of breast cancer--lifetime versus recent dietary intake. Epidemiology. 2007 May;18(3):373-82.

  Steck SE, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Santella RM, Gammon MD. Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis. 2007 Sep;28(9):1954-9. Epub 2007 Aug 11.

  Rossner P Jr, Terry MB, Gammon MD, Agrawal M, Zhang FF, Ferris JS, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM. Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med. 2007 Sep-Oct;11(5):1138-48.

  Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, Shen J, Long CM, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2033-41.

  Crew KD, Gammon MD, Terry MB, Zhang FF, Agrawal M, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk. Carcinogenesis. 2007 Dec;28(12):2548-51. Epub 2007 Oct 24.

  Xu X, Gammon MD, Zeisel SH, Lee YL, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. Choline metabolism and risk of breast cancer in a population-based study. FASEB J. 2008 Jun;22(6):2045-52. Epub 2008 Jan 29.

  Gammon MD, Fink BN, Steck SE, Wolff MS. Soy intake and breast cancer: elucidation of an unanswered question. Br J Cancer. 2008 Jan 15;98(1):2-3. Epub 2008 Jan 8. (No abstract available.)

  Shen J, Gammon MD, Terry MB, Teitelbaum SL, Eng SM, Neugut AI, Santella RM. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Eur J Cancer. 2008 Mar;44(5):710-7. Epub 2007 Nov 28.

  Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H. Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis. 2008 Apr;29(4):766-71. Epub 2008 Feb 14.

  Gaudet MM, Gammon MD, Bensen JT, Sagiv SK, Shantakumar S, Teitelbaum SL, Eng SM, Neugut AI, Santella RM. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York. Breast Cancer Res Treat. 2008 Mar;108(1):93-9. Epub 2007 Jul 12.

  Gammon MD, Santella RM. PAH, genetic susceptibility and breast cancer risk: an update from the Long Island Breast Cancer Study Project. Eur J Cancer. 2008 Mar;44(5):636-40. Epub 2008 Mar 7. (No abstract available.)

  Beyea J, Stellman SD, Hatch M, Gammon MD. Airborne emissions from 1961 to 2004 of benzo[a]pyrene from U.S. vehicles per km of travel based on tunnel studies. Environ Sci Technol. 2008 Oct 1;42(19):7315-20.

  Vo TT, Gladen BC, Cooper GS, Baird DD, Daniels JL, Gammon MD, Richardson DB. Dichlorodiphenyldichloroethane and polychlorinated biphenyls: intraindividual changes, correlations, and predictors in healthy women from the southeastern United States. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2729-36.

  Golembesky AK, Gammon MD, North KE, Bensen JT, Schroeder JC, Teitelbaum SL, Neugut AI, Santella RM. Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study. Carcinogenesis. 2008 Oct;29(10):1944-9. Epub 2008 Jun 26.

  McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB, North K, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Gammon MD. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect. 2009 Apr;117(4):552-8. Epub 2008 Dec 10.

  Bradshaw PT, Sagiv SK, Kabat GC, Satia JA, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Consumption of sweet foods and breast cancer risk: a case-control study of women on Long Island, New York. Cancer Causes Control. 2009 Apr 23. [Epub ahead of print]

  Shen J, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI, Santella RM. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer. 2009 Apr 1;124(7):1637-43.

  Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa). 2009 Jun;2(6):598-604. Epub 2009 May 26.

  • The citations above for the parent study "Breast Cancer and the Environment on Long Island" are current as of August, 2009. For information on papers published after this date, please, access the National Library of Medicine's PubMed scientific literature database. In the "for" box insert the grant number CA066572.

  Breast Cancer and the Environment on Long Island Follow-up Study

  Marilie D. Gammon, PhD
  University of North Carolina at Chapel Hill, N.C.
  (Formerly at Columbia University, NY)

  Fink BN, Gaudet MM, Britton JA, Abrahamson PE, Teitelbaum SL, Jacobson J, Bell P, Thomas JA, Kabat GC, Neugut AI, Gammon MD. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat Jul;98(2):199-208. Epub 2006 Mar 15.

  Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1803-11.

  Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Britton JA, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD. Active and passive cigarette smoke and breast cancer survival. Ann Epidemiol. 2007 May;17(5):385-93. Epub 2007 Mar 28.

  Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2285-92.

  Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G, Teitelbaum SL, Neugut AI, Santella RM, Chen J. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat. 2009 May;115(2):397-404. Epub 2008 Jun 3.

  Xu X, Gammon MD, Zeisel SH, Bradshaw PT, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J. High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J. 2009 Jul 27. [Epub ahead of print]

  Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, Desai M, Teitelbaum SL, Neugut AI, Jacobson JS. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer. 2009 Jul 15;115(14):3271-82.

  Xu X, Gammon MD, Wetmur JG, Bradshaw PT, Teitelbaum SL, Neugut AI, Santella RM, Chen J. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2109-16.

  Cleveland RJ, Gammon MD, Long CM, Gaudet MM, Eng SM, Teitelbaum SL, Neugut AI, Santella RM. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Res Treat. 2009 Aug 21. [Epub ahead of print]

  Rossner P Jr, Gammon MD, Zhang YJ, Terry MB, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G, Agrawal M, Kalra TS, Gaudet MM, Teitelbaum SL, Neugut AI, Santella RM. Mutations in p53, p53 protein overexpression and breast cancer survival. J Cell Mol Med. 2008 Oct 16. [Epub ahead of print]

  Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD. Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environ Res. 2009 Apr;109(3):287-91. Epub 2009 Jan 31.

  • The citations above for the "Breast Cancer and the Environment on Long Island Follow-up Study" are current as of August, 2009. For information on papers published after this date, please, access the National Library of Medicine's PubMed scientific literature database. In the "for" box insert the grant number CA066572.

  Electromagnetic Fields and Breast Cancer on Long Island

  M. Cristina Leske, MD, MPH
  Stony Brook University, NY

  Schoenfeld ER, Henderson K, O'Leary E, Grimson R, Kaune W, Leske MC. Magnetic field exposure assessment: a comparison of various methods. Bioelectromagnetics 1999 Dec;20(8):487-96.

  Caplan LS, Schoenfeld ER, O'Leary ES, Leske C. Breast cancer and electromagnetic fields--a review. Ann Epidemiol 2000 Jan;10(1):31-44.

  Schoenfeld ER, O'Leary ES, Henderson K, Grimson R, Kabat GC, Ahnn S, Kaune WT, Gammon MD, Leske MC; EBCLIS Group. Electromagnetic fields and breast cancer on Long Island: case-control study. Am J Epidemiol 2003 Jul 1;158(1):47-58.

  O'Leary ES, Schoenfeld ER, Henderson K, Grimson R, Kabat GC, Kaune WT, Gammon MD, Leske MC; EBCLIS Group. Wire coding in the EMF and Breast Cancer on Long Island Study: relationship to magnetic fields. J Expo Anal Environ Epidemiol 2003 Jul;13(4):283-93.

  Kabat GC, O'Leary ES, Schoenfeld ER, Greene JM, Grimson R, Henderson K, Kaune WT, Gammon MD, Britton JA, Teitelbaum SL, Neugut AI, Leske MC; EBCLIS Group. Electric blanket use and breast cancer on Long Island. Epidemiology 2003 Sep;14(5):514-20. Accompanying editorial: Sandler, D. Epidemiology 2003 Sep;14(5):509 (not available online).

  O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD, Leske MC. Shift Work, Light at Night, and Breast Cancer on Long Island, New York. Am J Epidemiol 2006 Aug 15;164(4):358-66. Epub 2006 Jun 15.

  Epidemiology of Breast Cancer and Serum Organochlorine and Serum Organochlorine Compounds and Breast Cancer on Long Island

  Steven D. Stellman, PhD
  Columbia University, New York, NY
  (Formerly at American Health Foundation, New York, NY)

  Wolff M, Camann D, Gammon M, Stellman S. Proposed PCB Congener Groupings for Epidemiologic Studies. Environmental Health Perspectives 105(1):13-14, January 1997.

  Stellman SD, Djordjevic MV, Muscat JE, Gong L, Bernstein D, Citron ML, White A, Kemeny M, Busch E, Nafziger AN. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev 1998 Jun;7(6):489-96.

  Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, Busch E, Gong L. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev 2000 Nov;9(11):1241-9.

  Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev 2003 Dec;12(12):1474-8.

  Environmental Exposures and Breast Cancer on Long Island

  Erin S. O'Leary, PhD
  Stony Brook University
  (Formerly at University of Buffalo, NY)

  O'Leary ES, Vena JE, Freudenheim JL, Brasure J. Pesticide exposure and risk of breast cancer: a nested case-control study of residentially stable women living on Long Island. Environ Res 2004 Feb;94(2):134-44.

  Organochlorine Compounds and Risk of Breast Cancer

  Tongzhang Zheng, MD, ScD
  Yale University, New Haven, CT

  Zheng T, Holford TR, Mayne ST, Tessari J, Owens PH, Zahm SH, Zhang B, Dubrow R, Ward B, Carter D, Boyle P. Environmental exposure to hexachlorobenzene (HCB) and risk of female breast cancer in Connecticut. Cancer Epidemiol Biomarkers Prev 1999 May;8(5):407-11.

  Zheng T, Holford TR, Mayne ST, Owens PH, Ward B, Carter D, Dubrow R, Zahm SH, Boyle P, Tessari J. Beta-benzene hexachloride in breast adipose tissue and risk of breast carcinoma. Cancer 1999 May 15;85(10):2212-8.

  Zheng T, Holford TR, Mayne ST, Ward B, Carter D, Owens PH, Dubrow R, Zahm SH, Boyle P, Archibeque S, Tessari J. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol 1999 Sep 1;150(5):453-8.

  Zheng T, Holford TR, Mayne ST, Tessari J, Ward B, Carter D, Owens PH, Boyle P, Dubrow R, Archibeque-Engle S, Dawood O, Zahm SH. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 2000 Feb;9(2):167-74.

  Zheng T, Holford TR, Tessari J, Mayne ST, Owens PH, Ward B, Carter D, Boyle P, Dubrow R, Archibeque-Engle S, Zahm SH. Breast cancer risk associated with congeners of polychlorinated biphenyls. Am J Epidemiol 2000 Jul 1;152(1):50-8.

  Reducing Barriers to Use of Breast Cancer Screening

  Dorothy S. Lane, MD, MPH
  Stony Brook University, NY

  Rakowski W, Andersen MR, Stoddard AM, Urban N, Rimer BK, Lane DS, Fox SA, Costanza ME. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol 1997 Sep;16(5):433-41.

  Stoddard AM, Rimer BK, Lane D, Fox SA, Lipkus I, Luckmann R, Avrunin JS, Sprachman S, Costanza M, Urban N. Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium. Prev Med 1998 May-Jun;27(3):478-87.

  Lane DS, Messina CR. Current perspectives on physician barriers to breast cancer screening. J Am Board Fam Pract 1999 Jan-Feb;12(1):8-15.

  Lane DS, Messina CR. Methodology for targeting physicians for interventions to improve breast cancer screening. Am J Prev Med 1999 May;16(4):289-97.

  Lane DS, Messina CR, Grimson R. An educational approach to improving physician breast cancer screening practices and counseling skills. Patient Educ Couns 2001 Jun;43(3):287-99.

  Stoddard AM, Fox SA, Costanza ME, Lane DS, Andersen MR, Urban N, Lipkus I, Rimer BK; Effectiveness of telephone counseling for mammography: results from five randomized trials. NCI Breast Screening Consortium. Prev Med 2002 Jan;34(1):90-9.

  Messina CR, Lane DS, Grimson R. Effectiveness of women's telephone counseling and physician education to improve mammography screening among women who underuse mammography. Ann Behav Med 2002 Fall;24(4):279-89.

  Estrogen Metabolites as Biomarkers for Breast Cancer Risk (Breast Cancer Risk and Inducibility of P450s)

  H. Leon Bradlow, PhD
  Strang Cancer Prevention Laboratory, New York, NY, and
  Geoffrey Kabat, PhD
  Stony Brook University, NY

  Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 1997 Jul;6(7):505-9.

  Regulation of Scatter Factor Expression in Breast Cancer

  Eliot M. Rosen, MD, PhD
  Long Island Jewish Medical Center
  Albert Einstein College of Medicine, New Hyde Park, NY

  Yao Y, Jin L, Fuchs A, Joseph A, Hastings HM, Goldberg ID, Rosen EM. Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am J Pathol 1996 Nov;149(5):1707-17.

  RDA Analysis of Breast Cancer

  Michael H. Wigler, PhD
  Cold Spring Harbor Laboratory
  Cold Spring Harbor, NY

  Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, Linehan WM, Reid BJ, Wigler MH. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):151-5.

  New Statistical Methodology for Determining Cancer Clusters

  Martin Kulldorff, PhD
  University of Connecticut Health Center
  School of Medicine, Farmington, CT
  (Formerly at the National Cancer Institute, Bethesda, Md.)

  Kulldorff M, Feuer EJ, Miller BA, Freedman LS. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol 1997 Jul 15;146(2):161-70.

  Geographic Influences on Women's Health

  Susan R. Sturgeon, DrPH
  University of Massachusetts
  School of Public Health, Amherst, Mass.
  (Formerly at the National Cancer Institute, Bethesda, Md.)

  Sturgeon SR, Graubard BI, Schairer C, McAdams M, Hoover RN, Gail MH. Population-density and county-level variation in breast cancer mortality rates among white women residing in the Northeastern and Southern United States. Cancer Causes Control 2003 Dec;14(10):923-31.

• Integrated Chemical List

  Some Long Island breast cancer advocates, who have been interested in the Long Island Breast Cancer Study Project (LIBCSP), submitted a list of chemicals and other agents of concern to them as possible causes of breast cancer. Many of the agents are already included in the LIBCSP. The table lists both the agents of community interest and those included in the LIBCSP, and is called the Integrated Chemical List.

  The table on the Integrated Chemical List was compiled by Ruth Allen, PhD, of the Environmental Protection Agency (EPA), and points to various sources of further information on the toxicology and carcinogenicity of the agents. The LIBCPS also appreciates the help of Richard Hill, PhD, of EPA, who coordinated obtaining the various databases for the effort. The table aggregates much information on the agents, but is not a comprehensive reference. You may be aware of other sources, and links to some are provided.

  Tips on using the Integrated Chemical List table:

  • Under Headings is listed the sources of information on the agents (e.g., NTP -- National Toxicology Program).
  • The Description box provides information about the source, and links to the sources' Web sites to access information on the agent of interest.
  • Quickly search our Web site by the agent's name, or the CAS number, by choosing "Find..." from the "Edit" menu of your browser (or typing Ctrl+F). Insert search words or numbers.
  • An agent may be listed under a synonym: One way to search for synonyms is to use CambridgeSoft CHEMFINDER. CHEMFINDER requires registration, but the service is free. This Web-based dictionary will help you obtain synonyms, and perhaps more importantly, the Chemical Abstract Service (CAS) registry number for the agent. The CAS number is a universally recognized identification number which is included in the Integrated Chemical List to help you identify agents. The external link to ChemFinder is provided as a service to our users; the company is not affiliated with the National Cancer Institute (NCI).
  • The EPA Regulatory Status heading mostly captures information on whether a pesticide has been granted a license, or registration, to permit its distribution, sale, and use according to specified requirements. EPA is required by law to review and reregister pesticides that were initially registered before November 1984. Reregistration Eligibility Decision (RED) indicates EPA has reviewed and reregistered the pesticide. Canceled means that the pesticide is no longer registered.

  
  

  The Headings are:

  Headings	Description
  chemical name/ CAS#/ Use/ EPA Regulatory Status	name of the agent Chemical Abstract Service (CAS) registry number (universal identification number to help identify agents with synonyms) use of the agent EPA Regulatory Status - registration, or license, status of the agent.
  NTP	The National Toxicology Program designs, conducts, and interprets animal assays for toxicity/carcinogenicity. NTP is part of the National Institute of Environmental Health Sciences (NIEHS), U.S. Department of Health and Human Services (DHHS). = information available in NTP
  ATSDR	The Agency for Toxic Substances and Disease Registry produces fact sheets, called ToxFAQs, about the adverse effects of exposure to many hazardous substances. ATSDR is part of DHHS. = fact sheet available
  BCERF	Program on Breast Cancer and Environmental Risk Factors in New York State provides fact sheets and other information on risk for breast cancer. Note: The BCERF program closed on 3/31/10. Archived research and educational materials can be accessed at http://ecommons.library.cornell.edu/handle/1813/14300. = fact sheet available
  IRIS	Integrated Risk Information System database provides information on human health effects that may result from exposure to various chemicals. IRIS was developed by EPA to provide its staff consistent information on chemical substances for risk assessments, decision making, and regulatory activities. = information available in IRIS
  TRI	Toxic Release Inventory database provides information on chemical releases and waste management activities, including state fact sheets that summarize annual release data by state. TRI is published by EPA. = information available in TRI
  GAP	Genetic Activity Profile database provides toxicity data on chemical agents from EPA priority chemical groups, and the International Agency for Research on Cancer Monographs. The database includes short-term test results abstracted from 8000 references on genetic toxicity. = information available in GAP
  IARC Carcinogenicity Assessment	The International Agency for Research on Cancer produces the IARC Monographs Database on Carcinogenic Risks to Humans. Information is summarized on agents evaluated based on weight of evidence for carcinogenicity. Readers may refer to the Monographs for background information on type(s) of cancer implicated or cited in the review. = agent is classified
  EPA Carcinogenicity Assessment	EPA performs its own carcinogenicity assessments and classifies the likehood of agents being human carcinogens based on weight of evidence. The classification system is described. = agent is classified
  LIBCSP	Agents tested for in the Long Island Breast Cancer Study Project are indicated by , along with the source of the agent (e.g., blood, water, soil)

  Access the Integrated Chemical List

* The acronym for the Geographic Information System for Breast Cancer Studies on Long Island was changed to LI GIS (from GIS-H) in 2004.